Despite the fact that many types of drugs work by blocking a G-protein-coupled receptor (GPCR), there are currently no approved cancer drugs that work this way. The existing scientific literature includes published papers, which observe that dopamine receptors have an effect on cancer but this connection raises a few key questions. 1.  Does it make sense…